Axel Dignass 1, Ayesha Akbar 2, Daniel C Baumgart 3, Gilles Bommelaer 4, Guillaume Bouguen 5, Guillaume Cadiot 6, Anton Gillessen 7, Jean-Charles Grimaud 8, Ailsa Hart 2, Syed Hoque 9, Richard Makins 10, Christophe Michiels 11, Jacques Moreau 12, Purushothaman Premchand 13, Wolfgang Ramlow 14, Stefan Schanz 15, Sreedhar Subramanian 16, Christian von Tirpitz 17, Bruno Bonaz 18 , Scand J Gastroenterol. 2018 Apr;53(4):442-448.
Evidencia científica
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis
This study confirms findings of the 12-week interim analysis and demonstrates that GMA apheresis provides a safe and beneficial long-term outcome for patients with chronic active UC resistant/intolerant to IS and/or TNF inhibitors.
ContáctanosPara solicitar información adicional
Contáctanos